Praxis Precision Medicines: Funding, Investors & Team (Oct 2026)
Praxis Precision Medicines is a company in the biopharmaceutical industry that focuses on developing treatments for central nervous system (CNS) disorders. They utilize genetic knowledge to address neuronal imbalances associated with these disorders. By leveraging their understanding of common biological targets and brain circuits, Praxis extends their research from genetic epilepsies to a wider range of neurological and psychiatric disorders.
Praxis Precision Medicines has raised $1.4B across 4 funding rounds on record, the most recent an undisclosed round of $575M announced in Jan 2026.
That round is above the $8.4M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Praxis Precision Medicines Company Profile and Key Stats
Latest funding round on record: Jan 2026.
Praxis Precision Medicines Funding Rounds
Praxis Precision Medicines raised $150M in an undisclosed round announced in Jan 2024.
2 months later, an undisclosed round of $200M was announced in Mar 2024.
1.6 years later, an undisclosed round of $525M was announced in Oct 2025.
3 months later, an undisclosed round of $575M was announced in Jan 2026.
Praxis Precision Medicines Founders and Leadership Team
Contact details for the Praxis Precision Medicines team: 1 of 1 has an email address on file.
Start 14-day free trial →Praxis Precision Medicines Funding Compared to Other Biotechnology Startups
Praxis Precision Medicines' latest round of $575M is above the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Praxis Precision Medicines in Biotechnology and Cambridge
Companies Similar to Praxis Precision Medicines
Prolific Machines is a biotech company located in San Francisco, California, that was established in 2020. It…
Altay Therapeutics is a biotech company focused on finding and discovering small molecule therapies for…
Kallyope, we believe that the gut is the gateway to our internal world. Containing millions of neurons, the…
Astrocyte Pharmaceuticals is a drug development company that helps in the recovery and well-being of brain…
Tiny Health offers a gut health test specifically designed for mothers and babies aged 0 to 3 years.…
Junevity is dedicated to using cutting-edge transcription factor medicines to combat age-related diseases.…
Arkea Bio creates technology aimed at reducing greenhouse gas (GHG) emissions in the agricultural sector.
Serán is a contract development and manufacturing organization providing a comprehensive suite of…
Precision’s goal is to provide breakthrough treatments for the one billion patients worldwide suffering from…
Enveda is a biotechnology company that utilizes AI-powered tools to explore and characterize molecules from…
Avery Therapeutics, Inc. is a company dedicated to developing tissue engineered therapeutics to treat…
Praxis Precision Medicines Funding FAQs
What does Praxis Precision Medicines do?
Praxis Precision Medicines is a company in the biopharmaceutical industry that focuses on developing treatments for central nervous system (CNS) disorders. They utilize genetic knowledge to address neuronal imbalances associated with these disorders. By leveraging their understanding of common biological targets and brain circuits, Praxis extends their research from genetic epilepsies to a wider range of neurological and psychiatric disorders.
How much funding has Praxis Precision Medicines raised?
Praxis Precision Medicines has raised $1.4B across 4 rounds on record. The most recent is an undisclosed round of $575M announced in Jan 2026.
When did Praxis Precision Medicines last raise funding?
Praxis Precision Medicines' most recent funding round on record is an undisclosed round of $575M, announced in Jan 2026.
Who founded Praxis Precision Medicines?
FundedIQ lists Steven Petrou (Founder) at Praxis Precision Medicines.
Where is Praxis Precision Medicines headquartered?
Praxis Precision Medicines is based in Cambridge, Massachusetts, United States.
How many employees does Praxis Precision Medicines have?
Praxis Precision Medicines is in the 51-100 employee band.
How does Praxis Precision Medicines' funding compare to other Biotechnology startups?
Praxis Precision Medicines' latest round of $575M is above the $8.4M median round size for Biotechnology companies on FundedIQ across 4,185 tracked companies over the last two years.
About FundedIQ's Praxis Precision Medicines Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Praxis Precision Medicines is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Startup funding intelligence on every funded startup: the round, the investors and the founders, as a file in your inbox or searchable in the app.
Radar from $49/mo · Pro from $149/mo. Card required, nothing charged until day 15, and we email you 3 days before that. Need something specific? Custom plans from $499/mo.